Assessment of Effectiveness and Side Effects of Subdermal Implant among User Women

Abstract

Background: Implanon is a progestin-only implantable contraceptive; it offers promise, long-term, with a high-efficacy contraceptive. It is one of the most effective reversible contraceptives and is of the same effectiveness to sterilization. Objective: To assess the adverse effect profile and effectiveness of subdermal implants. Materials and Methods: A prospective study involved 48 women attending for insertion of the subdermal implant on days 2-5 of their cycle. The implant was inserted subdermally under the effect of local xylocaine of the nondominant arm. Results: The commonest side effect was weight gain constituted 62.5%. At the same time, amenorrhea was reported in 31.3%. Pain at the site of insertion constitutes 14.6%. While bleeding occurred in one case, which responded to local pressure. The commonest cause of discontinuation was weight gain constituted 12.5%. Followed by disturbances in the menstrual cycle. Discontinuation rate 41.7% (20 out of 48 cases). Conclusion: Implanon is an effective long-term contraception with few adverse effects.